Natalie Sacks
Directeur/Bestuurslid bij CARIBOU BIOSCIENCES, INC.
Vermogen: 104 951 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Natalie Sacks
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.
46
| Subsidiary | Pharmaceuticals: Major | 46 |
The University of California, San Francisco
39
| College/University | Other Consumer Services | 39 |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Biotechnology | 20 | |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer.
18
| Extinct | Pharmaceuticals: Major | 18 |
| Public Company | Biotechnology | 14 | |
| Extinct | Pharmaceuticals: Major | 8 | |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark.
8
| Holding Company | Pharmaceuticals: Major | 8 |
| Public Company | Pharmaceuticals: Major | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Natalie Sacks via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Services to the Health Industry | Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Founder Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member General Counsel Director of Finance/CFO Public Communications Contact | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Corporate Officer/Principal Private Equity Investor | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Glasgow | College/University | Undergraduate Degree Doctorate Degree | |
| The Johns Hopkins University | College/University | Director/Board Member Masters Business Admin | |
| University of British Columbia | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director of Finance/CFO Corporate Officer/Principal | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member Director/Board Member | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Founder Chairman Chief Tech/Sci/R&D Officer | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
Rigontec GmbH
 Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Executive Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| RAIN ONCOLOGY INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of California San Diego | College/University | Director/Board Member Undergraduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Kovina Therapeutics, Inc.
 Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Kansas | College/University | Undergraduate Degree Undergraduate Degree | |
| ARIX BIOSCIENCE PLC | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
| The University of Texas Southwestern Medical Center | College/University | Corporate Officer/Principal Doctorate Degree | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Michigan | College/University | Corporate Officer/Principal Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Canada | 4 |
| Verenigd Koninkrijk | 4 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 18 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 460 |
| Corporate Officer/Principal | 232 |
| Independent Dir/Board Member | 144 |
| Undergraduate Degree | 80 |
| Chief Executive Officer | 79 |
Sterkste connecties
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Regina Hodits | 34 |
| William Ringo | 32 |
| Ted Love | 31 |
| Thomas Wiggans | 31 |
| Alan Colowick | 30 |
| N. Coles | 30 |
| Ken Galbraith | 30 |
| Sten Verland | 28 |
| Scott Braunstein | 25 |
| Pablo Cagnoni | 24 |
| Wendell Wierenga | 23 |
| Susan Mahony | 21 |
| Sharon Tetlow | 21 |
| Robert Williams | 20 |
- Beurs
- Insiders
- Natalie Sacks
- Bedrijfsconnecties